NUVL Royalty Pharma Acquires $315M Royalty Interest in Cancer Drug Candidates, 1.5% Royalty Rate
Nuvalent, Inc. Class A Common Stock · PHARMACEUTICAL PREPARATIONS · Now $93.01
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS